Glicociência

Phenyl a-D-thiogalactopyranoside is a sugar with a galactose and thioglucose residue linked by an alpha-1,6 glycosidic bond. It is obtained from the hydrolysis of starch or starch derivatives such as maltodextrin. This compound can be modified through various reactions, including fluorination, glycosylation, methylation, and modification. Phenyl a-D-thiogalactopyranoside has CAS number 5664-77-5 and molecular weight of 288.24 g/mol.

Catechol a-D-glucopyranoside is a synthetic monosaccharide, which can be used as the starting material for the synthesis of polysaccharides and oligosaccharides. It has the same molecular formula as glucose, but with an additional hydroxyl group on carbon 2.

2,3,4,5-Tetra-O-acetyl-D-xylononitrile is a carbohydrate with the chemical formula C10H14O8N2. It is a white crystalline solid that has been custom synthesized with high purity and methylation. This compound is an oligosaccharide with a sugar modification. The glycosylation of this compound is Click modification.

6'-Sialyllactose-APD-HSA is a complex carbohydrate that belongs to the group of oligosaccharides. It has a CAS number of 102600-80-4 and it is a polysaccharide. This compound is modified with methylation, glycosylation, and click modification. It is also fluorinated and synthesized.

Lipid X is a monosaccharide precursor of E. coli lipid A. It is an N-acyl-D-glucosamine 1-phosphate where the N-acyl group is (R)-3-hydroxytetradecanoyl and carrying an additional (R)-3-hydroxytetradecanoyl, and it is a component of the cell wall of Gram-negative bacteria. Due to its physiological functions and biological properties, Lipid X can be used to treat infectious diseases, autoimmune diseases, and HIV infection. It has also been shown to inhibit the production of inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β). This effect is due to its ability to disrupt hydrogen bonds between lipids in the cell membrane. As a biosynthetic intermediate of Lipid A, it seems to play a role in bacterial virulence and can trigger an immune response in humans, and protect against endotoxins.

Norfluoxetine is a selective serotonin reuptake inhibitor (SSRI) that is metabolized to the active metabolite, norfluoxetine b-D-glucuronide. The metabolism of norfluoxetine b-D-glucuronide has been shown to be inhibited by estradiol. Norfluoxetine b-D-glucuronide also exhibits antioxidant activity, which may be related to its ability to modulate expression of genes encoding antioxidant proteins. Norfluoxetine b-D-glucuronide has been found in wastewater and wastewater treatment plant effluents, suggesting this drug may have an environmental impact. The transcriptome of organisms exposed to norfluoxetine b-D-glucuronide has been studied and it was found that there are some genes that are responsive to this drug.

Methimazole is a drug that inhibits the synthesis of thyroid hormones by blocking the action of thyroperoxidase. Methimazole thio-b-D-glucuronide is a non-toxic, water-soluble derivative of methimazole. It is used in the treatment of hyperthyroidism and thyrotoxicosis. This compound can be synthesized from methimazole by click chemistry, fluorination or glycosylation. The product can be custom synthesized with high purity and high carbohydrate content.

Dipyridamole is a synthetic fluorinated sugar that is used in research as a model for natural oligosaccharides. It has been shown to be useful for investigating the glycosylation reactions of polysaccharides and proteins, as well as for studying carbohydrate-protein interactions. Dipyridamole mono-O-b-D-glucuronide is an example of a product that can be custom synthesized by our laboratory. The product has purity of >99% and CAS No. 63912-02-7.

D-Mannoheptulose is a natural analog of D-fructose that has been shown to have anticancer properties. It inhibits the growth and proliferation of cancer cells, induces apoptosis, and reduces tumor size. D-Mannoheptulose is a potent inhibitor of protein kinases, including the Chinese hamster ovary cell kinase (CHO-K1) and the human protein kinase C isoform βII. This compound has been found in urine and has potential as an anticancer agent. In addition, it has been studied as a potential inhibitor for diabetes drug saxagliptin.

1,6:2,3-Dianhydro-4-O-(2',3',4',6'-tetra-O-acetyl-b-D-glucopyranosyl)-b-D-mannopyranose is a custom synthesis of an oligosaccharide that contains a saccharide. It belongs to the class of carbohydrates and can be used in research as a fluorinated complex carbohydrate for modification. This product is not intended for human or animal consumption.

Gala1-3Gal-HSA is a modified glycan with three terminal alpha-galactoside units. It is synthesized by the modification of Gala1-3Gal (saccharide) with HSA. This product is also fluorinated, methylated and click-modified. The chemical name for this product is 3-[(2S,3S)-2,3-bis[(carboxymethyl)amino]propyl]-alpha-D-galactopyranosyl-(1→4)-O-[(carboxymethyl)(hydroxyethyl)]-.

6-O-Triisopropylsilyl-D-glucal is a silyl ether that can be used as a protecting group for benzyl alcohol. It is an efficient, large-scale synthesis of the benzyl alcohol and d-glucuronolactone. 6-O-Triisopropylsilyl-D-glucal accelerates the reaction by removing water as a byproduct of the reaction, simplifying the synthesis to just two steps. This product is also useful for synthesizing other products with similar structures.

Desthiobiotin is a modified form of biotin that binds less tightly to biomolecules like proteins and carbohydrates than it does biotin, while still providing excellent specificity in affinity purification methods (Hirsch, 2002). The structure of GD2-oligosaccharide-desthiobiotin (sodium salt) comprises (GalNAcβ1,4Galβ1,4Glc) of its two sialic acids linked α2,3/α2,8 to the central galactose residue (Ledeen, 2009). The desthiobiotin is attached β to position 1 of the reducing glucose moiety. GD2 ganglioside is expressed at a low concentration in the central nervous system, nerves, skin melanocytes and stem cells in healthy adults. On the other hand, GD2 ganglioside is overexpressed in a number of tumors including: neuroblastoma, melanoma, small cell lung carcinoma and brain tumors. Recently, GD2 ganglioside has been found in low concentration on breast cancer stem cells (CSC) that possess: self-renewal properties (division without disrupting the undifferentiated state) and tumor-initiating capabilities. It has been suggested that GD2 ganglioside may be developed as an effective target antigen for CSC immunotherapy (Fleurence, 2017).

Allyl 4,6-O-benzylidene-a-L-glucopyranoside is a glycosylation agent that is used in the synthesis of oligosaccharides. It is a synthetic compound that can be modified to produce complex carbohydrates. Allyl 4,6-O-benzylidene-a-L-glucopyranoside has been shown to be effective for the fluorination and methylation of sugar chains. It also has high purity and CAS number, which makes it an excellent choice for custom synthesis.

Fucose 2-nitrophenylhydrazone is a custom synthesis that is a modification of fucose. It has been used in methylation, click modification, and fluorination. This compound has been shown to be effective in the synthesis of oligosaccharides and polysaccharides. Fucose 2-nitrophenylhydrazone has also been used as an intermediate for the synthesis of saccharides such as monosaccharide and sugar.

1,3,6-Tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-2-azido-2-deoxy--D--glucopyranose is a modification of a natural sugar. It is an oligosaccharide that is composed of one monosaccharide and two disaccharides. The triacetate group on the first saccharide provides protection against hydrolysis and methylation reactions. This compound has been shown to be synthesized chemically in high purity and with high yield.

4,5,6-Tri-O-benzyl-3-benzyloxymethyl-octa-1,7-dien-3-ol is an oligosaccharide that is synthesized by the modification of a simple sugar with two benzyloxymethyl groups. It can be used as a carbohydrate in pharmaceuticals and other applications.

Blood group B trisacchharide-APE-HSA is a synthetic carbohydrate that inhibits the synthesis of complex carbohydrates. The methylation of saccharides and polysaccharides can be accomplished by the addition of an amine to the 3′ hydroxyl group. In this reaction, the sugar is attached to a protein carrier (e.g., human serum albumin) via an amide bond, which prevents its degradation by proteases in the body. The modification of saccharides and polysaccharides is also accomplished through click chemistry, which is based on copper catalysis. This process involves attaching two functional groups through a copper-mediated reaction, forming a new carbon-carbon bond. Modification of saccharides and oligosaccharides can be accomplished using either chemical or enzymatic methods. Sugar modification can be achieved using high purity enzymes that have been custom synthesized for specific purposes (e.g., glycosylation). Carbohydrate modification can

Imipramine N-b-D-glucuronide is a metabolite of imipramine. Imipramine N-b-D-glucuronide is soluble in water and ethanol, but not in ether or chloroform. It has a molecular weight of 592.9 g/mol, and the CAS number is 165602-94-8. Imipramine N-b-D-glucuronide is soluble in water and ethanol, but not in ether or chloroform. It has a molecular weight of 592.9 g/mol, and the CAS number is 165602-94-8. Imipramine N-b-D-glucuronide can be modified with a click reaction to introduce fluorines at any desired position on the sugar molecule. This modification can be used for glycosylation studies as well as for fluorescent labeling of glycoconjugates for use in imaging studies.

Ramipril acyl-b-D-glucuronide is a glycosylated prodrug that is the active form of ramipril, an ACE inhibitor. It is metabolized in the liver to ramipril and excreted in the urine. Ramipril acyl-b-D-glucuronide has been shown to have an increased bioavailability and a longer half-life than ramipril due to its glycosylation. The synthesis of this drug has been modified by methylation, fluorination, and saccharide modification. This compound is also available as a custom synthesis for research purposes with high purity.

2-Amino-2-deoxy-D-xylose is a metal chelator that can be used in the treatment of infections caused by bacteria. It has been shown to have synergistic effects with metaperiodate, a compound that inhibits bacterial growth by blocking the synthesis of folic acid. 2-Amino-2-deoxy-D-xylose also chelates and removes heavy metals such as mercury and lead from the bloodstream and other tissues. In addition, this drug is an efficient method for producing amino function pyrimidine nucleosides, which are precursors to DNA and RNA synthesis. The metal chelate ring is formed through dehydration of a furanose molecule with a chloride ion. This leads to an advanced carbohydrate product that contains chlorine.

Neocarrahexadecaose-41,3,5,7,9,11,13,15-octa-O-sulfate sodium salt is a carbohydrate that belongs to the group of modified saccharides. It is synthesized by modifying a sugar with fluorine and methylation. Neocarrahexadecaose-41,3,5,7,9,11,13,15-octa-O-sulfate sodium salt is an oligosaccharide with a high purity and custom synthesis. It is a synthetic compound that has been modified in order to create methylated and glycosylated sugars as well as a click modification. This carbohydrate has not yet been tested for toxicity or side effects in humans.

4'-Hydroxytrazodone b-D-glucuronide is a modification of the drug 4'-hydroxytrazodone, which is used to treat hypertension and depression. The modification prevents the degradation of 4'-hydroxytrazodone by glucuronyl transferase enzymes in the liver, prolonging its half-life. It is synthesized from the glycogen or starch of plants such as corn, wheat, or potatoes. This compound can also be found in natural sources such as honey and fruit juices.